TickerRisk
Learn Pricing Open Scanner

BIOGEN INC. (BIIB) Earnings Date & Options Risk

When BIIB reports next, and what it means for options pricing. ← Full BIIB risk overview

45
Risk Score
2026-07-30
Next Earnings
47.1%
IV Rank
MEDIUM
Risk Band
Biological Products, (No Diagnostic Substances)
Sector

How BIIB earnings affect options

BIOGEN INC. (BIIB) reports earnings on 2026-07-30, which falls inside a typical options expiry window. Earnings are the single biggest scheduled catalyst for an overnight gap: implied volatility usually runs up into the report and collapses immediately after (the IV crush). Selling premium into the event captures that crush but exposes you to the gap; buying premium needs a move large enough to beat the elevated IV you paid.

Scan BIIB before earnings — free

See the full risk breakdown around BIIB's earnings: IV vs HV, Expected Move, options flow and every other active catalyst.

Scan BIIB Now →

Other Health Care earnings pages

TickerRisk provides risk scoring for informational purposes only. Not financial advice. Options trading involves substantial risk of loss. Full disclaimer